1. Home
  2. PROF vs JRVR Comparison

PROF vs JRVR Comparison

Compare PROF & JRVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROF
  • JRVR
  • Stock Information
  • Founded
  • PROF N/A
  • JRVR 2002
  • Country
  • PROF Canada
  • JRVR Bermuda
  • Employees
  • PROF N/A
  • JRVR N/A
  • Industry
  • PROF Medical/Dental Instruments
  • JRVR Property-Casualty Insurers
  • Sector
  • PROF Health Care
  • JRVR Finance
  • Exchange
  • PROF Nasdaq
  • JRVR Nasdaq
  • Market Cap
  • PROF 164.4M
  • JRVR 189.0M
  • IPO Year
  • PROF N/A
  • JRVR 2005
  • Fundamental
  • Price
  • PROF $4.27
  • JRVR $4.84
  • Analyst Decision
  • PROF Strong Buy
  • JRVR Buy
  • Analyst Count
  • PROF 2
  • JRVR 4
  • Target Price
  • PROF $11.50
  • JRVR $6.06
  • AVG Volume (30 Days)
  • PROF 79.0K
  • JRVR 220.6K
  • Earning Date
  • PROF 05-08-2025
  • JRVR 05-05-2025
  • Dividend Yield
  • PROF N/A
  • JRVR 0.82%
  • EPS Growth
  • PROF N/A
  • JRVR N/A
  • EPS
  • PROF N/A
  • JRVR N/A
  • Revenue
  • PROF $11,862,000.00
  • JRVR $678,788,000.00
  • Revenue This Year
  • PROF $71.17
  • JRVR $3.10
  • Revenue Next Year
  • PROF $134.25
  • JRVR $6.74
  • P/E Ratio
  • PROF N/A
  • JRVR N/A
  • Revenue Growth
  • PROF 75.01
  • JRVR N/A
  • 52 Week Low
  • PROF $3.90
  • JRVR $3.00
  • 52 Week High
  • PROF $11.42
  • JRVR $9.09
  • Technical
  • Relative Strength Index (RSI)
  • PROF 34.68
  • JRVR 62.50
  • Support Level
  • PROF $4.62
  • JRVR $4.65
  • Resistance Level
  • PROF $5.62
  • JRVR $5.15
  • Average True Range (ATR)
  • PROF 0.42
  • JRVR 0.21
  • MACD
  • PROF -0.01
  • JRVR 0.02
  • Stochastic Oscillator
  • PROF 8.45
  • JRVR 64.16

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About JRVR James River Group Holdings Ltd.

James River Group Holdings Ltd owns and operates a group of specialty insurance and reinsurance companies. It reports business into three segments. The Excess and Surplus Lines segment, which is the key revenue driver, offers commercial excess and surplus lines liability and excess property insurance products; The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business, where it retains a minority share of the risk and seek to earn fee income by allowing other carriers and producers to use its licensure, ratings, expertise and infrastructure, and the Corporate and other segment consists of the management and treasury activities of holding companies, and equity compensation for the group.

Share on Social Networks: